Both in Biotechnology
Scilex Holding vs Acumen Pharmaceuticals
Over the past year SCLX returned −89.6% and ABOS returned −89.2%; their daily moves had a correlation of 0.11.
SCLX −89.6% ABOS −89.2%Growth of $1, one year, split-adjusted
| Metric | SCLX | ABOS |
|---|---|---|
| Price | $1.85 | $0.2344 |
| Market cap | $13.0M | $17.0M |
| Today | −1.07% | −2.21% |
| 1 month | −51.6% | −89.0% |
| 6 months | −82.8% | −90.7% |
| Year to date | −84.8% | −88.9% |
| 1 year | −88.8% | −89.4% |
| Revenue growth (YoY) | −22.8% | — |
| Gross margin | 51.9% | — |
| Net margin | −1501.3% | — |
| P/E (TTM) | — | — |
| Price / sales | 0.4× | — |
| Net cash | -$82.5M | $52.3M |
| Dividend yield | — | — |
| Volatility (60d) | 70.3% | 493.0% |
| Short % of float | 2.4% | 7.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).